The Dexcom G7 Continuous Glucose Monitoring (CGM) System eliminates the guesswork of managing diabetes at mealtime by measuring and sending your glucose numbers to your phone* in real time. With Dexcom G7 you can confidently make better, more informed food decisions because you’ll know how food affects your numbers.
Before you pick up the menu, pick up your phone
Everything about the revolutionary Dexcom G7 is designed to be effortless and easy-to-use. With just a glance, you can use real time readings to inform your decisions before and after a meal or snack.
Powerfully simple, delightfully small
Easy to apply, easy to set up, and easy to use1. Dexcom G7 automatically sends your numbers to your phone or receiver, no fingersticks†, no scanning. And it’s so small and comfortable that it’s easy to forget you are wearing it2.
‡Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Serving Up Best-in-Class Accuracy
Dexcom G7 is the most accurate CGM system1. The more accurate your CGM readings, the more confident you can be about what’s happening with your body.
Lower A1C3-7. Increase Confidence.
Dexcom G7 is proven to lower A1C, increase time in range, and improve quality of life3-8. When you’re making good food decisions, you can have better glucose control5,8-9 and more confidence at mealtime.
Most covered patients pay $20 or less per month for Dexcom CGM§.
Dexcom is the most covered CGM brand, and Dexcom CGM systems are the most affordable at pharmacy10,‡. And even if you don’t have coverage, you can take advantage of our pharmacy savings program and save over 50%.
*Smart devices sold separately.
Get Started with Dexcom
Take the first step towards better health! Glucose health is a critical part of overall health, and Dexcom has the best sensing solution for you or your loved one regardless of your health goals. We'll make getting started easy from the comfort of your home.
*Smart devices sold separately. For a list of compatible devices, visit dexcom.com/compatibility. †fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings. ‡Individual pricing may vary depending on commercial insurance coverage. §Individual pricing may vary depending on insurance coverage. IQVIA FIA retail data, paid sensor claims from 1/1/2022 to 2/28/2023.
1 Dexcom, Data on File, 2022. 2 Dexcom, Data on File, 2020 3 Beck, RW, et al. JAMA. 2017;317(4):371-378. 4 Beck RW, et al. Ann Intern Med. 2017;167(6): 365-374. 5 Martens T, et al. JAMA. 2021;325(22):2262-2272. 6 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 7 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879. 8 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39. 9 Ehrhardt N, et al. Clin Diabetes. 2020;38(2):126-131. 10 Dexcom, Data on File 2023
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. MAT-0710